Form 4: Abbott Labs VP Controller Sells Shares for Tax
Insider Transaction Report
Abbott Laboratories' Vice President and Controller, John A. McCoy Jr., reported the disposition of 79 common shares for tax liability at $132.66 per share.
Summary
- John A. McCoy Jr., Vice President and Controller of Abbott Laboratories, disposed of 79 common shares.
- The transaction occurred on September 1, 2025, at a price of $132.66 per share.
- This disposition was for the payment of tax liability, indicated by transaction code 'F'.
- Following this transaction, McCoy Jr. directly owns 20,982 common shares and indirectly owns 57 shares through the Abbott Laboratories Stock Retirement Trust.
Sentiment
Score: 5
Explanation: The filing reports a routine insider transaction for tax purposes, which is neutral in sentiment. It does not indicate any significant positive or negative developments for the company.
Positives
- The transaction is a routine disposition for tax purposes, not a discretionary sale, indicating no negative sentiment from the insider regarding the company's prospects.
Negatives
- No specific negative aspects are identified beyond the reduction in direct shareholding, which is a standard occurrence for tax-related dispositions.
Risks
- No specific risks are mentioned in this Form 4 filing.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance.
Industry Context
This insider transaction is a routine event for a large, established pharmaceutical and medical device company like Abbott Laboratories and does not reflect broader industry trends or competitive dynamics.
Comparison to Industry Standards
- This is a routine insider transaction for tax purposes, common across all industries for executives receiving equity compensation. It does not provide a basis for comparison to specific industry benchmarks or competitor performance.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Grant | John A. McCoy, Jr. granted Power of Attorney to three individuals (Elizabeth C. Cushman, Jessica H. Paik, and Aaron N. Rice) to prepare, sign, and file SEC forms and documents on his behalf. This is a standard practice to ensure timely compliance with federal securities laws. | 2025-06-17 | Enhances efficiency and compliance for insider reporting requirements by delegating filing authority to legal representatives. |
Related Party Transactions
- The disposition of shares by John A. McCoy Jr., an officer of Abbott Laboratories, constitutes a related party transaction, specifically an insider transaction.
Stakeholder Impact
- The impact on shareholders is minimal as this is a small, routine transaction for tax purposes by an individual officer and does not reflect a change in company fundamentals or strategy.
- No direct impact on employees, customers, suppliers, or creditors is indicated by this filing.
Key Dates
| Date | Description |
|---|---|
| 2025-06-17 | Date John A. McCoy, Jr. granted Power of Attorney to Elizabeth C. Cushman, Jessica H. Paik, and Aaron N. Rice for SEC filings. |
| 2025-09-01 | Date of the reported transaction where 79 common shares were disposed of. |
| 2025-09-01 | Date for the balance in the Abbott Laboratories Stock Retirement Trust. |
| 2025-09-03 | Date the Form 4 was signed by Jessica H. Paik, Attorney-in-Fact for John A. McCoy, Jr. |
Keywords
Abbott Laboratories, ABT, Form 4, Insider Transaction, Share Disposition, John A. McCoy Jr., Vice President, Controller, Tax Liability, Common Shares
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.